Spruce Biosciences, Inc. (SPRB) Stock Grade

About Spruce Biosciences, Inc.'s fundamentals

Spruce Biosciences is a small-cap biotechnology company with a market capitalization of $66.8 million that reported a net loss in its latest annual statement, reflecting typical pre-commercial or early-stage biotech operations. The company generated no dividend yield and reported zero net margin, indicating it is not currently profitable. Revenue declined 100% year-over-year, suggesting either a transition in business operations or the conclusion of revenue-generating activities in the measured period.